Clinical trial
The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial
NCT00156819 · JHSPH Center for Clinical Trials, Other · Completed
Key facts
| NCT number | NCT00156819 |
|---|---|
| Title | The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial |
| Official title | The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial |
| Lead sponsor | JHSPH Center for Clinical Trials, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | fluticasone, montelukast, Fluticasone plus salmeterol |
| Enrollment | 500 |
| Start date | Jun 1, 2003 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Dec 9, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: